CATALOGO DEI PRODOTTI DELLA RICERCA

GISONDI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.417
NA - Nord America 6.613
AS - Asia 3.902
SA - Sud America 402
AF - Africa 128
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.526
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.551
SG - Singapore 1.836
GB - Regno Unito 1.827
IT - Italia 1.656
CN - Cina 1.516
RU - Federazione Russa 784
IE - Irlanda 640
FR - Francia 575
SE - Svezia 541
DE - Germania 517
FI - Finlandia 432
BR - Brasile 350
UA - Ucraina 121
NL - Olanda 88
ID - Indonesia 84
TR - Turchia 77
HK - Hong Kong 75
KR - Corea 73
TG - Togo 72
AU - Australia 53
ES - Italia 40
IN - India 39
JP - Giappone 38
CA - Canada 36
AT - Austria 32
BE - Belgio 28
IR - Iran 24
CH - Svizzera 21
MX - Messico 20
PL - Polonia 19
CL - Cile 15
CZ - Repubblica Ceca 14
EG - Egitto 14
MY - Malesia 14
SA - Arabia Saudita 14
DK - Danimarca 12
UZ - Uzbekistan 12
PK - Pakistan 11
PH - Filippine 10
AR - Argentina 9
DZ - Algeria 9
EC - Ecuador 9
IL - Israele 9
MA - Marocco 9
RO - Romania 9
VN - Vietnam 8
ZA - Sudafrica 8
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
TH - Thailandia 7
CO - Colombia 6
HR - Croazia 6
JO - Giordania 6
MM - Myanmar 6
TN - Tunisia 6
AL - Albania 5
BD - Bangladesh 5
BO - Bolivia 5
HU - Ungheria 5
IS - Islanda 5
LT - Lituania 5
TW - Taiwan 5
BG - Bulgaria 4
EE - Estonia 4
ET - Etiopia 4
GR - Grecia 4
LK - Sri Lanka 4
AM - Armenia 3
BN - Brunei Darussalam 3
EU - Europa 3
GE - Georgia 3
LV - Lettonia 3
NO - Norvegia 3
PY - Paraguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
GH - Ghana 2
IQ - Iraq 2
LU - Lussemburgo 2
OM - Oman 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BZ - Belize 1
CG - Congo 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
GY - Guiana 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
NG - Nigeria 1
Totale 18.518
Salva come PNG Salva come JPEG
Città #
Southend 1.591
Singapore 1.096
Chandler 1.055
Jacksonville 952
Dublin 629
Woodbridge 551
Ashburn 450
Ann Arbor 431
Houston 428
Beijing 248
Wilmington 220
Lawrence 215
Princeton 215
Helsinki 139
Jinan 135
Nanjing 130
Milan 126
New York 114
Verona 112
Rome 102
Shenyang 100
Sindelfingen 93
Munich 91
Jakarta 74
Lomé 72
The Dalles 65
Hebei 63
Hong Kong 61
Haikou 54
Tianjin 50
Changsha 48
Washington 48
Moscow 46
Seattle 46
Guangzhou 44
Nanchang 44
Redwood City 42
Santa Clara 42
Hangzhou 37
Bologna 35
Zhengzhou 34
Dallas 33
Jiaxing 32
Boardman 31
Los Angeles 31
Falls Church 29
Kent 29
Ningbo 28
Amsterdam 27
Brussels 27
Chicago 27
Redmond 27
Esslingen am Neckar 25
Turin 25
Lappeenranta 23
Venice 23
Fairfield 22
Taizhou 22
Genoa 21
Naples 21
Norwalk 21
Council Bluffs 20
Nuremberg 20
Vienna 20
Florence 19
London 19
Parma 19
Seoul 19
Shanghai 18
Sydney 18
Düsseldorf 17
São Paulo 17
Dongguan 16
Lancaster 16
Vicenza 16
Frankfurt am Main 15
Fuzhou 15
Bari 14
Belo Horizonte 14
Brescia 14
Kuala Lumpur 14
Tokyo 14
Toronto 14
Taiyuan 13
Edinburgh 12
Enfield 12
Madrid 12
Rio de Janeiro 12
Atlanta 11
Palermo 11
Phoenix 11
Santiago 11
Tashkent 11
Pescara 10
Catania 9
Curitiba 9
Lanzhou 9
Mumbai 9
Perth 9
San Jose 9
Totale 11.200
Salva come PNG Salva come JPEG
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 612
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 359
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 319
Dietary supplements for lipedema 230
A systematic review of treatments for pityriasis lichenoides 216
Il ruolo della vitamina D nella dermatite atopica 186
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 118
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 115
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 115
Polymorphisms, diet and nutrigenomics 114
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 113
Squamous cell carcinoma arising in lupus vulgaris. 109
Impact of TNF-α antagonists on the quality of life in selected skin diseases 109
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 108
Vitamin D levels in patients with psoriasis with or without arthritis 108
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 108
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 107
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 104
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 104
Severe impairment of quality of life in Hailey-Hailey disease. 103
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 102
Retention rate of systemic drugs in patients with chronic plaque psoriasis 100
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 98
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 98
Advanced Glycation End Products in the Pathogenesis of Psoriasis 96
Psoriasis and the metabolic syndrome 95
Psoriasi. Una guida per una migliore gestione del paziente. 93
Incidence of respiratory and allergic symptoms in Italian and immigrant children 93
Lebbra lepromatosa. 92
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 92
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 92
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 92
The expectations of patients with psoriasis during an office consultation 92
Heat urticaria: a revision of published cases with an update on classification and management 92
Psoriasis, the liver, and the gastrointestinal tract 91
Impact of the COVID-19 pandemic on melanoma diagnosis 91
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 90
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 90
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 90
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 89
Acneiform eruption induced by cetuximab 89
Pimecrolimus in dermatology: atopic dermatitis and beyond. 88
Targeting TNF-a in psoriasis and psoriatic arthritis. 88
Attitude to treatment of patients with psoriasis attending SPA center 88
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 88
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 87
The metabolic syndrome in psoriasis 87
Image Gallery: Pyoderma gangrenosum of the penis. 87
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis 87
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 86
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 86
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 86
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 84
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 84
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 83
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 83
The diagnostic and therapeutic challenge of early psoriatic arthritis 82
The importance of treating mild atopic dermatitis. 81
Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study 81
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 81
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 80
Targeting tumor necrosis factor a in the therapy of psoriasis. 80
Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis 80
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. 79
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 79
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. 78
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. 78
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 78
Hyperuricaemia in patients with chronic plaque psoriasis. 78
Dermatite atopica. 77
Complicanze dell'obesità: la cute 77
Microcircolatory modifications of psoriatic lesions during topical therapy. 77
Effects of secukinumab on serum adipocytokines: preliminary data 77
Aggiornamento sulla terapie biologiche della psoriasi 76
Patients with psoriasis have a higher prevalence of parental cardiovascular disease 76
Imiquimod: un ruolo nel trattamento topico della epidermodisplasia verruciforme? 76
PSORIASIS 76
Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making. 75
Metabolic comorbidities and psoriasis. 75
L’organo pelle: struttura, biologia, funzioni. 75
Chronic plaque psoriasis is associated with increased arterial stiffness 74
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 74
Vitamin D status in patients with chronic plaque psoriasis 73
Autoimmune progesterone dermatitis. 72
Usefulness of the Framingham risk score in patients with chronic psoriasis 72
Le malattie della mucosa orale 72
Systemic therapy of psoriasis in diabetic patients 72
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 72
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 72
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. 71
Cardiometabolic comorbidities: the fingerprint of psoriasis 71
Psodisk, a new visual method for assessing the burden of psoriasis on patients. 71
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. 71
Biologic therapies in psoriasis: a new therapeutic approach 71
Perception of disease and doctor-patient relationship experienced by patients with psoriasis. A questionnaire-based study 71
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 71
The need for long-term continuous therapy in moderate to severe chronic plaque psoriasis 70
Phenotypes of atopic dermatitis 70
La dermatite atopica nella seconda infanzia ed adolescenza 70
Concept of Remission in Chronic Plaque Psoriasis 70
Totale 10.008
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.191
article - articoli 75.575
book - libri 288
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.328
Totale 156.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020416 0 0 0 0 0 0 0 0 0 147 98 171
2020/20211.571 130 295 66 168 199 198 42 100 100 27 184 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.858 269 238 357 605 270 889 66 195 503 213 181 72
2023/20242.533 119 197 240 281 261 403 149 157 35 110 342 239
2024/20254.415 386 349 230 1.037 360 299 414 308 941 91 0 0
Totale 18.889